APA (7th ed.) Citation

Shi, G., Wang, J., Huang, X., Huang, X., He, Y., Ji, Y., . . . Zhou, J. (2021). Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors. Liver transplantation, 27(3), 444-449. https://doi.org/10.1002/lt.25887

Chicago Style (17th ed.) Citation

Shi, Guo‐Ming, et al. "Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors." Liver Transplantation 27, no. 3 (2021): 444-449. https://doi.org/10.1002/lt.25887.

MLA (9th ed.) Citation

Shi, Guo‐Ming, et al. "Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors." Liver Transplantation, vol. 27, no. 3, 2021, pp. 444-449, https://doi.org/10.1002/lt.25887.